Home     About SABCS     Press Releases     Media     Event Photos     Past Symposia     Satellite Symposia     Patient Advocates     FAQs     Contact Us



Registration           Hotel           Support & Exhibits     2014 Overview           Program           Travel & Transportation          

Meeting Profile
Symposium Objective
Scientific Program
Target Audience
Financial Philosophy
Symposium Administration
Audience Composition
Accreditation
Location
Future Meeting Dates
Symposium Contact
History
Previous Meetings
Susan G. Komen® Brinker Award for Scientific Distinction
William L. McGuire Memorial Lecture Award
American Association for Cancer Research Awards
Participating Countries in 2013

About SABCS

Meeting Profile

 

For thirty-seven years, the Symposium’s mission has been to provide state-of-the-art information on breast cancer research.  From a one-day regional conference, the Symposium has grown to a five-day program attended by a broad international audience of academic and private researchers and physicians from over 90 countries.

The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer.

In 2007, the Cancer Therapy & Research Center (CTRC) at UT Health Science Center San Antonio and the American Association for Cancer Research (AACR) announced a collaboration for the future of the San Antonio Breast Cancer Symposium.  The Symposium has been renamed the CTRC-AACR San Antonio Breast Cancer Symposium.  Complementing the clinical strengths of the highly regarded annual San Antonio Breast Cancer Symposium, the AACR's scientific prestige in basic, translational and clinical cancer research will create a unique and comprehensive scientific meeting that will advance breast cancer research for the benefit of patients.

In 2005, Baylor College of Medicine became a joint sponsor of the symposium and will remain in the CTRC-AACR collaboration.

C. Kent Osborne, MD, Director, Professor of Medicine and Molecular and Cellular Biology, Director, Dan L. Duncan Cancer Center, Director, Breast Center, Baylor College of Medicine, Ismail Jatoi, MD, Professor and Division Chief Surgical Oncology, UT Health Science Center San Antonio and Carlos L. Arteaga, MD, Professor of Medicine and Cancer Biology, Associate Director for Clinical Research, Director Breast Cancer Program Vanderbilt-Ingram Cancer Center, Vanderbilt University are Co-Directors of the Symposium.

Top
 
Spacer

Symposium Objective


This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

Top
 
Spacer

Scientific Program

The scientific program consists of plenary lectures and mini-symposia by experts in clinical and basic research; selected slide and poster presentations chosen from the submitted abstracts; educational sessions, award lectures, panel and case discussions and forums. General sessions are approximately 2 hours in duration and are the vehicle for slide presentations, which are allotted 10 minutes each followed by 5 minutes of discussion. Poster sessions are 1 1/2 to 2 hours long.

Top
 
Spacer

Target Audience

This international symposium is directed primarily towards academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as other appropriate health care professionals.

Top
Spacer

Financial Philosophy

Any remaining funds at the conclusion of the CME activity will be used for educational research purposes.

Top
 
Spacer

Symposium Administration

 

Co-Directors

C. Kent Osborne, MD, Director, Professor of Medicine and Molecular and Cellular Biology, Director, Dan L. Duncan Cancer Center, Director, Breast Center, Baylor College of Medicine, Houston, Texas, USA


Ismail Jatoi, MD, Professor and Division Chief Surgical Oncology, UT Health Science Center San Antonio, San Antonio, Texas, USA


Carlos L. Arteaga, MD, Professor of Medicine and Cancer Biology, Associate Director for Clinical Research, Director, Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA

Program Coordinator

Gary C. Chamness, Baylor College of Medicine, Houston, TX, USA


Director, Symposia

Rich Markow, UT Health Science Center, San Antonio, TX , USA

All administrative functions of the San Antonio Breast Cancer Symposium occur in the symposium operations office, which is located at Cancer Therapy & Research Center, 7979 Wurzbach, San Antonio, Texas 78229.

Top
 
Spacer

Audience Composition

The majority of participants are physicians and researchers, with smaller representation by affiliated health care professionals.

2013 San Antonio Breast Cancer Symposium there were 7,403 Symposium attendees + 85 Media + 137 Exhibitors, Non-Exhibiting Sponsors & their Support Staff = 7,625 total attendance.

More than 55% came from 106 countries outside the USA. Click here to view an audited 2013 SABCS registration report, which includes further details.

 

Top
 
Spacer

Accreditation

The UT Health Science Center San Antonio School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

This activity has been approved for AMA PRA Category 1 Credit

Top
 
Spacer
Spacer

Location

Henry B. Gonzalez Convention Center, 200 E. Market Street, San Antonio, Texas 78205, is the meeting site.

Top
 
Spacer
Spacer

Future Meeting Dates

 

  • December 8-12, 2015
  • December 6-10, 2016
  • December 5-9, 2017
Top
 
Spacer

Symposium Contact

Mr. Rich Markow, Director, Symposia
Cancer Therapy & Research Center at UT Health Science Center San Antonio

7979 Wurzbach Road, MC 8224

San Antonio, TX 78229
210-450-1550
210-450-1560 FAX
Email: sabcs@uthscsa.edu
Website Address: www.sabcs.org

Top
 
Spacer

History

The First Annual San Antonio Breast Cancer Symposium was held November 11, 1978 during Breast Cancer Awareness Week, and was part of an intensive 3-year outreach program of public and professional education designed to significantly reduce the death rate caused by breast cancer in San Antonio and surrounding counties. It was sponsored by Cancer Therapy and Research Center (CTRC) and the American Cancer Society, Texas Division, in conjunction with The University of Texas Health Science Center at San Antonio (UTHSCSA) and the Bexar County Medical Society. That all-day course for physicians and surgeons was organized and co-directed by Charles A. Coltman, Jr., MD and William L. McGuire, MD, both Professors of Medicine at UTHSCSA. It featured invited presentations by a panel of internationally known specialists and was attended by 141 physicians and surgeons from a 5-state area. Three years later, in 1981, the meeting was expanded to two days, a call for abstracts was distributed worldwide, and proffered papers for slide and poster presentations were incorporated into the program, thereby broadening its scope to both attract and draw from a larger, international base. Renowned experts gave formal plenary lectures, and accepted abstracts were published for the first time in the peer-reviewed journal Breast Cancer Research and Treatment. Case discussion lunches offered opportunity for discussion of complex clinical problems in the management of primary and metastatic disease, by a panel of physicians from different disciplines.


Although some modifications have been made in the format, such as incorporating pre-symposium educational sessions, Year In Review and lunchtime forums the overall format remains very much
the same. This reflects the objective of the Symposium, which is to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.


In 1990, CTRC and UTHSCSA formally entered into a collaboration known as the San Antonio Cancer Institute (an NCI designated Comprehensive Cancer Center), which in 1995 assumed direct sponsorship of the Symposium. In 1992, C. Kent Osborne, MD became Co-Director of the symposium upon the death of William L. McGuire, MD. In 1999, Dr. Osborne left UTHSCSA and opened the Breast Center at Baylor College of Medicine, and in 2005, Baylor College of Medicine became a joint sponsor of the symposium. In 2008 the American Association for Cancer Research became a joint sponsor of the symposium. Through the efforts of UTHSCSA, AACR, and BCM, the program attracts more thought-leaders and high-quality proffered papers in basic and translational breast cancer research as well as increasing the participation of young investigators by providing superior education and training opportunities for the next generation of breast cancer researchers.


The driving force behind the collaboration is the shared mission of the partners to advance progress against breast cancer. By combining their respective strengths, the partnership will produce a scientific meeting that encompasses the full spectrum of breast cancer research, facilitating the rapid translation of new knowledge into better care for breast cancer patients.


In 2010 Peter M. Ravdin, MD, PhD, Ruth McLean Bowman Bowers Chair for Breast Cancer Research & Treatment, Director of the Breast Cancer Program at the Cancer Therapy & Research Center at UT Health Science Center assumed the role of Co-Director of the symposium upon the retirement of Charles A. Coltman, Jr, MD. Dr. Coltman remains Co-Director, ex-officio.


In 2011 Carlos L. Arteaga, Professor of Medicine and Cancer Biology, Interim Director, Division of Hematology-Oncology, Director, Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University was appointed Co-Director of the symposium representing American Association for Cancer Research.

 

In 2014 Ismail Jatoi, MD, Professor and Division Chief Surgical Oncology at UT Health Science Center assumed the role of Co-Director of the symposium upon the retirement of Peter M. Ravdin, MD, PhD.


The UT Health Science Center San Antonio School of Medicine, through the Office of Continuing Medical Education, continues to be the provider of CME sponsorship for this premier breast cancer symposium.

All administrative functions are the responsibility of the Symposia Director and occur in the Symposium operations office, which is located at Cancer Therapy & Research Center, 7979 Wurzbach, San Antonio, Texas 78229. All proceeds from registration and abstract fees, industry educational grants, and exhibit fees, are used for Symposium development and operations, and for support of its staff which consists of the Symposia Director, the Senior Meeting Planner, the Meeting Planner and the Administrative Assistant.

Top
 
Spacer

Previous Meetings

1990-2012

Year

Year No.

Registrations

Papers Accepted

Exhibitors
No. of Countries

1990

13th

526

201

15
24

1991

14th

685

237

23
25

1992

15th

749

218

22
22

1993

16th

763

240

23
26

1994

17th

1,056

264

28
29

1995

18th

1,283

301

20
38

1996

19th

1,533

303

22
42

1997

20th

1,980

365

40
43

1998

21st

2,530

433

40
47

1999

22nd

3,126

450

40
55
2000
23rd
3,796
438
40
61

2001

24th

3,320

432
38
52
2002
25th 4,876 543 56 67

2003

26th

5,820

590
68
82
2004
27th
6,810 721
84
86
2005
28th
7,666 805
106
89
2006
29th
8,017 893
97
83
2007
30th
8,503 813
105
86
2008
31st
8,936
1,064
98
92
2009
32nd
8,493 1,169
102
93
2010
33rd
7,913
1,035
91
93
2011
34th
7,724 1,264
79
103
2012
35th
7,584
1,432
68
96
2013
36th
7,625 1,298
65
107

Top
 
Spacer

Susan G. Komen® Award for Scientific Distinction

Established by the Susan G. Komen for the Cure® in 1992, the Brinker Award for Scientific Distinction recognizes leading scientists for significant work in advancing research concepts and for clinical application in the fields of breast cancer research, screening or treatment. The award is presented to basic and clinical researchers who have made seminal advances in the fight against breast cancer.  In addition, the award recognizes scholars for a specific contribution, a consistent pattern of contributions, or leadership in the field that has had a substantial impact on the fight against breast cancer.

The Brinker Award is accompanied by a cash award to be used to further the recipients' activities in breast cancer research. This award has grown in prominence in the breast cancer community and is a marquee award for Komen for the Cure. The recipients of the Brinker Awards will deliver plenary lectures during the symposium. 

The award recipients since 1992 are:

Year

Basic Research
Clinical Research

1992

V. Craig Jordan, PhD
DSc Bernard Fisher, MD
1993
Arnold J. Levine, PhD
Richard J. Santen, MD
1994
Marc E. Lippman, MD
Malcolm C. Pike, PhD
1995
Helene S. Smith, PhD (deceased)
C. Kent Osborne, MD
1996
Edison Liu, MD
Umberto Veronesi, MD
1997
David Livingston, MD
Gabriel Hortobagyi, MD
1998
Leland H. Harwell, PhD
Henry T. Lynch, MD
1999
Mary-Claire King, PhD
Nancy E. Davidson, MD
2000
Angela Brodie, PhD
Dmitiros Trichopoulos, MD
2001
Bert O'Malley, MD
Jay Robert Harris, MD
2002 V. Elwood Jensen, PhD Charles L. Loprinzi, MD
2003
Mina J. Bissell, PhD
Walter C. Willett, MD, DrPH
2004
Daniel Medina, PhD
Larry Norton, MD
2005

Trevor J. Powles, PhD, FRCP, CBE and

Anita B. Roberts, PhD (deceased)

Michael B. Sporn, MD
2006
Evan Simpson, PhD
George W. Sledge, Jr., MD
2007
Joe W. Gray, PhD
Leslie Bernstein, PhD
2008
Patricia Steeg, PhD

Richard Gelber, PhD and

Aron Goldhirsch, MD

2009

Geoffrey L. Greene, PhD and
Benita S. Katzenellenbogen, PhD

Professor Ian E. Smith, MD
2010
Jeffrey M. Rosen, PhD
Soonmyung "Soon" Paik, MD
2011

Carlos L. Arteaga, MD

Armando E. Giuliano, MD, FACS, FRCSEd

2012
Yosef Yarden, PhD
Hyman B. Muss, MD
2013
Gordon B. Mills, MD, PhD
Edith A. Perez, MD
Top
 
Spacer

William L. McGuire Memorial Lecture Award

Dr. William L. McGuire, along with Dr. Charles A. Coltman, founded the San Antonio Breast Cancer Symposium in 1977.  The William L. McGuire Memorial Lectureship was established in 1992 to commemorate the significant contributions of Dr. McGuire to oncology medicine. His research played a major role in introducing estrogen receptor assays on breast tumor tissue as a guide to treatment decisions for women with breast cancer. Breast cancer patients everywhere now receive these tests.

The award recipients since 1992 are:

Year William L. McGuire Memorial Lecture
1992 Marc Lippman, MD
1993
Bernard Fisher, MD
1994 Craig Jordan, PhD, DSc
1995 Bert O’Malley, MD
1996
Benita S. Katzenellenbogen, PhD
1997 Kathryn Bloch Horwitz, PhD
1998 C. Kent Osborne, MD
1999 Charles A. Coltman, Jr., MD
2000 Trevor J. Powles, MD PhD
2001 Nancy E. Davidson, MD
2002 Michael Baum, MD
2003 Umberto Veronesi, MD
2004 Amy S. Langer, MBA
2005 Dennis J. Slamon, MD, PhD
2006 Richard J. Santen, MD
2007 Mitchell Dowsett, PhD
2008 Larry Norton, MD
2009

Martine Piccart, MD, PhD

2010
George W. Sledge, Jr., MD
2011 Joe Gray, PhD
2012

Gabriel N. Hortobagyi, MD

2013 Monica Morrow, MD, FACS

 

Top
 
Spacer

American Association for Cancer Research Awards

AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen® is presented to an investigator no more than 50 years of age whose novel and significant work that has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer.

 

AACR Distinguished Lectureship in Breast Cancer Research

The AACR Distinguished Lectureship in Breast Cancer Research has been established to recognize outstanding science that has inspired or has the potential to inspire new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer.

The award recipients since 2008 are:

Year
Outstanding Investigator Award for Breast Cancer Research
Distinguished Lectureship in Breast Cancer Research
2008

Douglas Easton, PhD, FMedSci

Joan Massagué, PhD

2009

Charles Perou, PhD

Robert Weinberg, PhD

2010
Klaus Pantel, MD, PhD
Alan Ashworth, PhD, FMedSci, FRS
2011
Ramon E. Parsons, MD, PhD

Joan S. Brugge, PhD

2012

Kornelia Polyak, MD, PhD

Mina J. Bissell, PhD

2013
Jason S. Carroll, PhD
Michael Stratton, FMEDSCI, FRS

 

Top
Spacer

Participating Countries in 2013
In 2013, registrants from the following countries participated.

                

Algeria

American Samoa

Angola

Argentina

Aruba

Australia

Austria

Bahamas

Bahrain

Bangladesh

Belarus

Belgium

Bolivia

Bosnia & Herzegowina

Brazil

Bulgaria

Canada

Chile

China

Colombia

Costa Rica

Croatia

Cyprus

Czech Republic

Denmark

Dominican Republic

Ecuador

Egypt

El Salvador

Finland

France

Georgia

Germany

Ghana

Greece

Guadeloupe

Guatemala

Honduras

Hong Kong

Hungary

Iceland

India

Indonesia

Iran

Iraq

Ireland

Israel

Italy

Japan

Jordan

Kazakhstan

Kuwait

Latvia                  

            

Lebanon

Libya

Macedonia

Malaysia

Martinique

Mexico

Montenegro

Morocco

Netherlands

Netherlands Antilles

New Zealand

Nigeria

Norway

Oman

Pakistan

Palestine

Panama

Paraguay

Peru

Philippines

Poland

Portugal

Puerto Rico

Qatar

Reunion

Romania

Russia

Saudi Arabia

Serbia

Singapore

Slovakia

Slovenia

South Africa

South Korea

Spain

St. Kitts and Nevis

Sweden

Switzerland

Taiwan

Thailand

Trinidad And Tobago

Tunisia

Turkey

Uganda

Ukraine

United Arab Emirates

United Kingdom

United States Of America (including APO & FPO)

Uruguay

Uzbekistan

Venezuela

Vietnam

Top
 
Home | About SABCS | Press Releases | Media | Event Photos | Past Symposia | Satellite Symposia | Patient Advocates | FAQs | Contact Us
Registration | Hotel | Support & Exhibits | 2014 Overview | Program | Travel & Transportation

Rich Markow, Director, Symposia
Cancer Therapy & Research Center at UT Health Science Center San Antonio

7979 Wurzbach Road, MC 8224 San Antonio, TX 78229 USA
Phone: 210-450-1550    Fax: 210-450-1560    Email: sabcs@uthscsa.edu
       line
Copyright 2014 SABCS. All rights reserved. - Privacy Policy